The biotech industry looks ripe for more gains after posting a second consecutive year of...
The biotech industry looks ripe for more gains after posting a second consecutive year of profits and seeing M&A activity heat up, says Karvy Global Services. Crunching the numbers reveals 8 stocks with implied upside potential based on quarterly results and analyst recommendations. Picks: HITK, CELG, DNDN, WX, TEVA, ILMN, CRL, BIIB.
From other sites
at CNBC.com (Jan 23, 2014)
at CNBC.com (Aug 27, 2013)
at MarketWatch.com (Sep 5, 2012)
at CNBC.com (Jul 16, 2012)
at MarketWatch.com (Jul 10, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs